Movie
Controller
Structure viewers
About EMN search
-Search query
-Search result
Showing 1 - 50 of 58 items for (author: silva & gm)
EMDB-70791: 
Cryo-EM structure of the DDB1/CRBN-MRT-5702-G3BP2 ternary complex
Method: single particle / : Quan C, Petzold G, Gainza P, Tsai J, Bunker RD, Wiedmer L, Donckele EJ
EMDB-45139:
nsEM map of macaque 32647 week 6 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-48283:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
EMDB-48286:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
EMDB-48287:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
EMDB-48290:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
EMDB-48291:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
EMDB-70490:
BG505 GT1.1 SOSIP in complex with gp41-base epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB
EMDB-70491:
BG505 GT1.1 SOSIP in complex with V1V2V3 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB
EMDB-70492:
BG505 GT1.1 SOSIP in complex with C3V5 epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB
EMDB-70493:
BG505 GT1.1 SOSIP in complex with CD4bs epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB
EMDB-70494:
BG505 GT1.1 SOSIP in complex with gp41 glycan hole epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB
EMDB-70495:
BG505 GT1.1 SOSIP in complex with gp41 fusion peptide epitope polyclonal antibodies isolated from a participant in the IAVI C101 clinical trial
Method: single particle / : Ozorowski G, Ward AB
PDB-9mi0:
61-12A01 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
PDB-9mia:
206-3G08 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
PDB-9mib:
206-9C09 Fab in complex with HIV-1 GT1.1 v4.1 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
PDB-9mih:
273-4D01 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
PDB-9mii:
253-7A03 Fab in complex with HIV-1 BG505 SOSIP Env trimer and RM20A3 Fab
Method: single particle / : Phulera S, Ozorowski G, Ward AB
EMDB-45102:
nsEM map of macaque 32653 week 42 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45140:
nsEM map of macaque 32653 week 6 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45141:
nsEM map of macaque 32647 week 10 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45142:
nsEM map of macaque 32653 week 10 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45143:
nsEM map of macaque 32647 week 14 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45144:
nsEM map of macaque 32653 week 14 polyclonal Fab in complex with BG505 v5.2 Prime immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45145:
nsEM map of macaque 32647 week 18 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45146:
nsEM map of macaque 32653 week 18 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45147:
nsEM map of macaque 32647 week 22 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45148:
nsEM map of macaque 32653 week 22 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-45149:
nsEM map of macaque 32653 week 26 polyclonal Fab in complex with BG505 v5.2 Boost #2 immunogen
Method: single particle / : Pratap PP, Cottrell CA, Ward AB
EMDB-40796:
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB
PDB-8sw3:
BG505 GT1.1 SOSIP in complex with NHP Fabs 12C11 and RM20A3
Method: single particle / : Zhang S, Torres JL, Ozorowski G, Ward AB
EMDB-40981:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40982:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2e:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP3
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8t2f:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody N289
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40797:
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Zhang S, Ward AB
PDB-8sw4:
BG505 GT1.1 SOSIP in complex with NHP Fabs 21N13, 21M20 and RM20A3
Method: single particle / : Ozorowski G, Torres JL, Zhang S, Ward AB
EMDB-40822:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
EMDB-40823:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40824:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swv:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF1
Method: single particle / : Pratap PP, Antansijevic A, Ozorowski G, Ward AB
PDB-8sww:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody IF3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
PDB-8swx:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40803:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody FP2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40804:
BG505 Boost2 SOSIP.664 in complex with NHP Polyclonal Antibody FP4
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40805:
BG505 Boost 2 in complex with NHP antibody V1V2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40806:
BG505 Boost 2 in complex with NHP Polyclonal Antibody N625
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40807:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base1
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40808:
Boost 2 SOSIP.664 in complex with NHP polyclonal antibody Base2
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
EMDB-40809:
BG505 Boost2 SOSIP.664 in complex with NHP polyclonal antibody Base3
Method: single particle / : Pratap PP, Antansijevic A, Ward AB
Pages:
wwPDB to switch to version 3 of the EMDB data model
